Skip to main content

Table 3 Correlation between the 5-year disease-specific survival rate and clinicopathological features in oral squamous cell carcinoma (OSCC)

From: Clinical significance of erythropoietin receptor expression in oral squamous cell carcinoma

Variables Number of patients 5-Year disease-specific survival rate (%) p-Value
Gender
Male 239 64.8 0.174
Female 17 81.9  
EPOR
Low expression 146 73.5 0.0017*
High expression 110 55.9  
Age, years
<60 202 67.9 0.142
≥60 54 58.6  
T classification
T1, T2 94 81.9 <0.001*
T3, T4 162 56.6  
N classification
Negative 153 79.4 <0.001*
Positive 103 45.8  
TNM stage
I, II 66 90.9 <0.001*
III, IV 190 57.2  
  1. EPOR: erythropoietin receptor; *statistically significant (p < 0.05).